Jamil Welch brings 20 years of expertise in the pharmaceutical industry with large, midsized, and small pharma clients. 

Jamil Welch currently resides in Charlotte, NC. He has an undergraduate degree in Mass Communications from North Carolina State University. In addition, he has a Master of Science degree in Kinesiology from Texas A&M University Corpus Christi. Jamil’s career in the pharmaceutical industry with large, midsized, and small pharma clients spans approximately 20 years with over 18 years in a leadership position. 

Throughout his tenure, Jamil progressed from an entry level position to Director of Commercial Strategy prior to transitioning into the manufacturer space. Formerly, as the Director of Market Access, he managed all specialty pharmacy relationships and contracting as well as engaged with payers to drive patient access. He recently served as the Director of Patient Support for an organization moving toward launching an MDMA-assisted therapy for adults with post-traumatic stress disorder (PTSD) pending FDA approval. Jamil has extensive knowledge in launching and providing oversight of patient access and support programs to include field reimbursement, patient assistance, QuickStart, bridge, voucher, rebate and copay programs among other company specific access initiatives. His skillset includes establishing performance metrics, standard operating procedures (SOPs), business rules documents (BRDs) and other key strategic elements that guide performance along with product growth. Ensuring patients access to therapy is Jamil’s primary objective. 

Jamil Welch

Patient Services

Jamil Welch brings 20 years of expertise in the pharmaceutical industry with large, midsized, and small pharma clients.

Jamil Welch currently resides in Charlotte, NC. He has an undergraduate degree in Mass Communications from North Carolina State University. In addition, he has a Master of Science degree in Kinesiology from Texas A&M University Corpus Christi. Jamil’s career in the pharmaceutical industry with large, midsized, and small pharma clients spans approximately 20 years with over 18 years in a leadership position.

Throughout his tenure, Jamil progressed from an entry level position to Director of Commercial Strategy prior to transitioning into the manufacturer space. Formerly, as the Director of Market Access, he managed all specialty pharmacy relationships and contracting as well as engaged with payers to drive patient access. He recently served as the Director of Patient Support for an organization moving toward launching an MDMA-assisted therapy for adults with post-traumatic stress disorder (PTSD) pending FDA approval. Jamil has extensive knowledge in launching and providing oversight of patient access and support programs to include field reimbursement, patient assistance, QuickStart, bridge, voucher, rebate and copay programs among other company specific access initiatives. His skillset includes establishing performance metrics, standard operating procedures (SOPs), business rules documents (BRDs) and other key strategic elements that guide performance along with product growth. Ensuring patients access to therapy is Jamil’s primary objective.